Brynjelsen Sean
Eton Pharmaceuticals, Inc. · President & CEO
Brynjelsen Sean is listed in filings as President & CEO at Eton Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 29, 2026, including sale activity. Recent filings connect the profile to Eton Pharmaceuticals, Inc. (ETON). The current snapshot covers public activity from Dec 12, 2025 to May 29, 2026. Reported amounts are shown as $113.3K to $2.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $4M119.9k shares | SellMay 28, 2026 | $31.88 | $40.12 |